Detalhe da pesquisa
1.
Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.
Thorax
; 72(4): 318-326, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27852955
2.
Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study.
J Cyst Fibros
; 23(1): 50-57, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666709
3.
Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design.
BMJ Open Respir Res
; 9(1)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710144
4.
Clinical Effectiveness of Lumacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for F508del-CFTR. A Clinical Trial.
Ann Am Thorac Soc
; 18(1): 75-83, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32644818
5.
Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients.
J Cyst Fibros
; 20(2): 333-338, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32917547
6.
The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network.
J Cyst Fibros
; 20(2): 195-197, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33349583
7.
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design.
Ann Am Thorac Soc
; 18(8): 1397-1405, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33465316
8.
PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy.
J Cyst Fibros
; 20(2): 205-212, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619012